Infographic | Cell therapies: CAR-T versus CAR-NK
Chimeric antigen receptor (CAR) cell therapies are a rapidly developing potential therapeutic option for patients with cancer and autoimmune diseases. But what does CAR therapy look like and what are the differences between CAR-T and CAR-NK therapies? This feature was supported by Sino Biological.
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!
